This bill establishes the INCLUDE Project at the National Institutes of Health (NIH) to advance research on Down syndrome and related health conditions. It requires NIH to fund high-risk studies on trisomy 21, support inclusive clinical trials for people with Down syndrome across all ages, and investigate co-occurring conditions like Alzheimer’s disease and autoimmunity. The law mandates NIH coordination across its institutes, consultation with patient advocates, and biennial reports to Congress detailing funded research and its real-world applications. The project directly affects individuals with Down syndrome, their families, and medical researchers, aiming to improve diagnosis, treatment, and quality of life through targeted scientific efforts.
This bill reauthorizes the National Earthquake Hazards Reduction Program through fiscal year 2030, providing $83.4 million annually with $30 million each year dedicated to completing the Advanced National Seismic System. It expands the program to include Tribal governments, updates standards to cover building design, evaluation, and post-earthquake recovery (such as minimizing downtime for critical infrastructure), and requires better coordination between federal agencies like the USGS, Federal Communications Commission, and FEMA for earthquake early warnings. The bill mandates that early warning alerts be broadcast in the predominant languages of affected regions and includes new provisions for tsunami response coordination and data sharing.
HR 2821, the FDA Modernization Act 3.0, requires the FDA to update regulatory language within one year of enactment. It directs the agency to replace all references to "animal tests" with "nonclinical tests" in 22 specific sections of the Code of Federal Regulations related to drug development and approval processes. The bill also adds a definition for "nonclinical test" into relevant FDA regulations to align with prior legislative changes. This update applies directly to pharmaceutical manufacturers and FDA reviewers who follow these regulatory guidelines during drug development. The changes aim to modernize terminology without altering current testing requirements.
HR 2715, the *Destruction of Hazardous Imports Act*, expands the authority to destroy imported goods that pose public health risks. It amends the Federal Food, Drug, and Cosmetic Act to allow the Secretary of Health and Human Services to order the destruction of any refused import (not just drugs or devices) if it presents a significant health concern. The bill also prohibits the unauthorized movement, sale, or export of such refused goods. These changes apply to importers of hazardous refused articles 180 days after enactment, with the FDA required to finalize implementing regulations within 90 days.
HR 2306 extends the Adams Memorial Commission's authority until 2032 and authorizes $50 million in federal funds for the memorial, requiring a 1:1 non-federal match and limiting administrative costs to 4% of federal funds. It updates location rules to allow the memorial within a designated area mapped by the Commission. The bill primarily affects the Adams Memorial Commission and entities contributing to the memorial's funding. It makes no new policy changes but adjusts procedural timelines and funding requirements for an existing commemorative project.
This bill reauthorizes and improves federal programs focused on preventing, detecting, and treating traumatic brain injuries (TBIs), extending funding through 2030. It updates CDC surveillance to better track high-risk groups (like military personnel, first responders, and those in certain occupations) and requires public sharing of aggregated TBI data. States receiving grants must maintain non-Federal funding levels for TBI programs, with limited waivers allowed. The bill also mandates a congressional report on high-risk populations and a study examining long-term TBI effects, including links to dementia and mental health conditions.
The Medicare Advantage Supplemental Benefits Transparency Act of 2026 requires Medicare Advantage plans to submit detailed data on supplemental benefits to the federal government starting in 2029. This information will include specific details about what benefits are offered, eligibility rules, and how much each enrollee spends on these services. The Centers for Medicare & Medicaid Services will then make this de-identified data available to the public and researchers for analysis after a two-year delay. To support the implementation of these reporting requirements, the bill appropriates $12 million for fiscal year 2026.
HR 2913, the Ukraine Support Act, provides comprehensive U.S. support for Ukraine in response to Russia's invasion. The bill authorizes security assistance including lend-lease authority for military equipment, establishes a Ukraine Reconstruction Trust Fund for economic recovery, and imposes new sanctions targeting Russian financial institutions, oil companies, and government officials. It also includes provisions to counter Russian disinformation, support Radio Free Europe, and address the kidnapping of Ukrainian children. The legislation directly affects U.S. foreign policy, Ukraine's defense capabilities, and Russia's access to international financial systems. The act aims to strengthen Ukraine's sovereignty while holding Russia accountable for its actions.
The Save MEDICARE Act of 2026 aims to improve the Medicare Advantage program by starting in 2028 with several changes to how health plans are paid and monitored. It requires the government to exclude diagnoses from chart reviews when calculating payments to prevent plans from inflating costs based on questionable data. The bill also speeds up audits and appeals to ensure faster resolution of coding disputes and introduces a new penalty system to recover overpayments from plans. Additionally, the law allows states to enforce Medicare rules within their borders and bans financial incentives for doctors based on how they code patient records. Finally, it establishes a mechanism for the Department of Veterans Affairs to recover costs when Medicare Advantage plans cover care that should have been paid for by the VA.
This bill requires the Veterans Health Administration to publish more detailed staffing and vacancy data for the public. It mandates that information about specific job positions be released monthly rather than quarterly, while other general staffing data continues to be updated on a quarterly schedule. The changes aim to increase transparency by making it easier to track open roles and workforce status at medical facilities. This legislation directly affects the VA's reporting processes and provides the public with more frequent access to employment information.
This resolution honors the life and legacy of the late Senator Lindsey Olin Graham from South Carolina. It formally acknowledges his extensive career in the military, state government, and Congress, noting his service as a Senator and his roles as Chairman of the Judiciary and Budget committees. The Senate expresses its sorrow over his death and requests that this tribute be shared with the House of Representatives and Graham's family.
This bill establishes a comprehensive sanctions framework targeting the Russian government and its affiliated entities in response to ongoing military actions. It authorizes the President to block assets, revoke visas, and prohibit financial transactions for Russian officials, military leaders, and foreign persons supporting Russia's defense industry or undermining Ukraine. The legislation also bans U.S. investments in Russian energy sectors, prohibits the purchase of Russian sovereign debt, and imposes high tariffs on Russian imports while restricting crude oil purchases by specific foreign nations. Additionally, the bill prevents Russian companies from listing on U.S. stock exchanges and includes mechanisms for terminating sanctions only if Russia signs a peace agreement accepted by Ukraine and ceases hostilities.
